Wearable Trackers Add Steps, but Usually Not Intensity

Wearable trackers can help people move more, but a higher step count is not the same thing as more exercise. The best pediatric evidence finds that trackers increase daily steps while leaving moderate-to-vigorous physical activity (MVPA) essentially unchanged. In older adults, MVPA can rise, but the successful programs do far more than display a step total.

That distinction should shape how you use a watch, ring, or fitness band. A device can make walking more visible and goals more immediate. It cannot, by itself, reliably turn a casual stroll into sustained brisk activity, cycling, strength work, or sport. Those require planning, accountability, and a reason to keep showing up after the new-device glow fades.

The clearest finding: more steps in children, no more MVPA

The strongest study here is a 2024 systematic review and meta-analysis in The Lancet Digital Health. Au et al. pooled 21 randomized controlled trials involving 3,676 children and adolescents, whose mean age was 13.7 years. Compared with control conditions, wearable activity trackers increased daily step counts by a standardized mean difference (SMD) of 0.37 (95% confidence interval [CI], 0.09 to 0.65; p=0.013).

An SMD expresses an effect relative to variation within the included studies, so it does not provide one universal number of added steps for every child. The positive result also varied substantially among trials: the full paper reports high heterogeneity for the step outcome. Some settings, devices, and programs likely work better than others.

The more clinically revealing result came from the 11 trials that measured MVPA. The pooled effect was SMD −0.08 (95% CI, −0.18 to 0.02; p=0.11), which was not statistically significant. Between-study heterogeneity was 0%, meaning these trials produced remarkably similar estimates around no meaningful change in MVPA.

This does not mean the added steps have no value. Hamaya et al. reported dose-response associations between step-based activity measures and cardiovascular health outcomes, with benefits beginning at modest step counts. But association between steps and health outcomes does not prove that a tracker-caused step increase produces the same benefit, and it does not convert low-intensity movement into MVPA.

Why step goals can miss the exercise target

Step-based interfaces reward what they can count easily: frequent movement. That can mean walks, errands, pacing during calls, or extra laps around the kitchen while deciding what to eat. All of those movements can be useful. They also demand less effort than activities that raise heart rate for sustained periods.

Nuss et al., in a systematic review of motivational interviewing paired with wearable trackers, used self-determination theory to explain this gap. Achievable step targets can build a sense of competence, but that feedback may not create enough autonomous motivation for higher-intensity activity. A tracker is good at making an attainable goal feel attainable. It is less good at persuading someone to do hill intervals on a wet Tuesday.

A 2025 study of older adults by Chen et al. estimated that roughly 3,000 additional daily steps corresponded to 30 minutes of moderate-intensity activity. That conversion came from adults aged 65 years or older and should not be treated as a precise rule for children, whose gait and energy expenditure differ. It does, however, illustrate the scale of the problem: a modest step increase does not automatically supply a large block of moderate exercise.

Older adults improve when the device is part of a program

The evidence is more encouraging when digital tools sit inside a broader behavior-change intervention. A 2025 systematic review and meta-analysis by Wang et al. examined mHealth interventions in adults aged 55 and older. MVPA reached an SMD of 0.48, while physical-activity effects across broader outcome categories ranged from SMD 0.18 to 0.48.

Those are not estimates for passive step counting alone. Larger effects appeared in interventions that combined at least three behavior-change technique clusters, such as feedback and monitoring, goal-setting and planning, social support, and comparison with outcomes. Programs grounded in self-determination theory or the Transtheoretical Model also performed better. The practical lesson is simple: a wearable can contribute to a program, but it is rarely the program.

That pattern appears in a 2025 randomized trial by Kim et al.. Older adults received a wearable integrated with a structured home-based multicomponent exercise intervention, and the trial found improved physical function and fall-related measures. Because the intervention bundled the tracker with structured exercise, the result cannot isolate the wearable as the cause. It does show that technology can support useful outcomes when a real exercise plan surrounds it.

The same principle helps explain a randomized trial in adults with knee osteoarthritis. In the Delaware PEAK trial, participants received telehealth physical therapy, strengthening exercises, education, and daily step goals over 12 weeks; the study tested whether that package increased MVPA compared with web-based osteoarthritis resources. This was clinician-guided rehabilitation with step targets, not a test of buying a tracker and waiting for transformation.

More activity did not change BMI

Wang et al. found no significant change in body mass index despite the activity gains in older adults. BMI is a blunt measure, but the null result still matters. An intervention can change movement behavior without producing measurable body-size change during the studied period. Do not read an 'active minutes' graph as evidence that a device has changed body composition.

This is one reason health claims need endpoint discipline. Steps and MVPA are behavior measures. BMI is an anthropometric outcome. Fall-related measures and physical function are clinical outcomes. A favorable result in one category does not guarantee a favorable result in the next.

The maintenance problem arrives after the honeymoon

Short trials can capture the period when a new device, app, or challenge still feels fresh. Long-term evidence is thinner. The 12-month IMPACT randomized trial, reported by Valle et al., studied young adult cancer survivors using an mHealth intervention and found that physical-activity maintenance had substantially attenuated by 12 months compared with earlier outcomes.

Cancer survivors face barriers that may not match those of healthy adults, including fatigue and deconditioning, so the result cannot set a universal expiration date for motivation. Still, it is the longest follow-up in this body of evidence, and it argues against treating early engagement as durable behavior change. A separate 2025 mHealth weight-loss study by Bizhanova et al. also found different adherence trajectories: some participants sustained prescribed activity goals while others disengaged quickly.

Adherence can improve with reinforcement. A 180-day randomized trial in 111 heart-failure patients by Mohapatra et al. tested connected monitoring devices alone, monitoring plus gamification, and monitoring plus gamification with a financial incentive. The study found that the app-based approaches improved adherence to mobile monitoring, while also noting that adherence tends to decline over time. Monitoring engagement is not identical to exercise behavior, but it captures a familiar problem: apps need upkeep too.

What the evidence supports

Wearable and smartphone interventions have increased physical activity in adults as well. Laranjo et al. synthesized adult studies of smartphone apps and activity trackers and found significant physical-activity gains; their metaregression also identified behavior-change content and theoretical grounding as relevant moderators. The exact pooled adult estimates are not available from the published abstract, so they should not be treated as interchangeable with the pediatric or older-adult numbers.

Research in clinical populations and outside Western settings also supports the broad conclusion that digital tools can raise activity. For example, a review of breast-cancer-survivor trials found wearable interventions improved physical activity and health-related outcomes, while a review in the Middle East and North Africa found mobile technologies promoted physical activity and reduced sedentary behavior. Those findings extend the signal across populations; they do not erase differences in intervention design, setting, or outcome measurement.

A tracker is most useful as a measuring tool attached to a plan: schedule demanding sessions, set heart-rate-zone or active-minute goals when appropriate, recruit accountability, and refresh goals before engagement declines.

The evidence does not support calling passive tracking a body-composition intervention or a dependable route to higher-intensity exercise. It supports a narrower, more useful claim: wearables can add movement, especially steps. For bigger and more durable changes, the device needs behavioral structure around it.